Skip to main content
Erschienen in: Journal of Cancer Survivorship 3/2017

31.01.2017

The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period

verfasst von: Devesh Oberoi, Victoria White, John Seymour, H. Miles Prince, Simon Harrison, Michael Jefford, Ingrid Winship, David Hill, Damien Bolton, Anne Kay, Jeremy Millar, Nicole Wong Doo, Graham Giles

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study is to examine the course of anxiety, depression and unmet needs in diffuse large B cell lymphoma (DLBCL) and multiple myeloma (MM) survivors in the first 2 years post diagnosis.

Methods

DLBCL and MM survivors, recruited through the Victorian Cancer Registry, completed two interviews approximately 7 and 15 months post diagnosis. Hospital Anxiety and Depression Scale (HADS) and Supportive Care Needs Survey (SCNS-SF34) were completed at both interviews. Primary outcomes were prevalence of anxiety, depression and unmet needs (any or moderate–high). Generalized estimating equation examined whether course of anxiety, depression and unmet needs differed between the two cancers.

Results

Overall, 236 DLBCL and 178 MM survivors completed both telephone interviews. Course of anxiety differed (p < 0.01) with rate increasing in DLBCL (14 to 22%) while remaining stable for MM (15 to 12%). Course of depression also differed (p < 0.01), decreasing for MM (22 to 12%) and remaining stable for DLBCL (15 to 16%) survivors. Change in unmet needs was generally similar for the two cancer groups, except for moderate to high psychological needs (p < 0.05).

Conclusions

Patterns of change in anxiety and depression in first 2 years post diagnosis differ for DLBCL and MM survivors.

Implications for cancer survivors

Studying psychological outcomes in mixed haematological cancer samples may be inappropriate, at least in the early survivorship phase. Separate studies of the experiences of people with the different haematological cancer subtypes are needed to ensure psychosocial and supportive care interventions are appropriate to the needs of individuals with different haematological cancers.
Literatur
3.
Zurück zum Zitat Armitage JO. My treatment approach to patients with diffuse large B-cell lymphoma. Mayo Clinic proceedings: Elsevier. 2012:161–71. Armitage JO. My treatment approach to patients with diffuse large B-cell lymphoma. Mayo Clinic proceedings: Elsevier. 2012:161–71.
4.
Zurück zum Zitat Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28(5):1122–8. doi:10.1038/leu.2013.313.CrossRefPubMed Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28(5):1122–8. doi:10.​1038/​leu.​2013.​313.CrossRefPubMed
5.
Zurück zum Zitat Howlader N NA, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2013. Retreived from URL http://seer.cancer.gov/csr/1975_2013/. Bethesda, MD: National Cancer Institute; 2016. Howlader N NA, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2013. Retreived from URL http://​seer.​cancer.​gov/​csr/​1975_​2013/​. Bethesda, MD: National Cancer Institute; 2016.
6.
Zurück zum Zitat Eslick R, Talaulikar D. Multiple myeloma: from diagnosis to treatment. Aust Fam Physician. 2013;42(10):684.PubMed Eslick R, Talaulikar D. Multiple myeloma: from diagnosis to treatment. Aust Fam Physician. 2013;42(10):684.PubMed
8.
Zurück zum Zitat Wang Z-Y, Liu L, Shi M, Wang L. Exploring correlations between positive psychological resources and symptoms of psychological distress among hematological cancer patients: a cross-sectional study. Psychol Health Med. 2015;21(5):571–82. doi:10.1080/13548506.2015.CrossRefPubMed Wang Z-Y, Liu L, Shi M, Wang L. Exploring correlations between positive psychological resources and symptoms of psychological distress among hematological cancer patients: a cross-sectional study. Psychol Health Med. 2015;21(5):571–82. doi:10.​1080/​13548506.​2015.CrossRefPubMed
9.
Zurück zum Zitat Bergerot CD, Clark KL, Nonino A, Waliany S, Buso MM, Loscalzo M. Course of distress, anxiety, and depression in hematological cancer patients: association between gender and grade of neoplasm. Palliat Support Care. 2015;13(02):115–23.CrossRefPubMed Bergerot CD, Clark KL, Nonino A, Waliany S, Buso MM, Loscalzo M. Course of distress, anxiety, and depression in hematological cancer patients: association between gender and grade of neoplasm. Palliat Support Care. 2015;13(02):115–23.CrossRefPubMed
11.
Zurück zum Zitat Oerlemans S, Mols F, Nijziel MR, Zijlstra WP, Coebergh JWW, van de Poll-Franse LV. The course of anxiety and depression for patients with Hodgkin’s lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry. J Cancer Surviv. 2014;8(4):555–64. doi:10.1007/s11764-014-0367-1.CrossRefPubMed Oerlemans S, Mols F, Nijziel MR, Zijlstra WP, Coebergh JWW, van de Poll-Franse LV. The course of anxiety and depression for patients with Hodgkin’s lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry. J Cancer Surviv. 2014;8(4):555–64. doi:10.​1007/​s11764-014-0367-1.CrossRefPubMed
12.
Zurück zum Zitat Priscilla D, Hamidin A, Azhar MZ, Noorjan KON, Salmiah MS, Bahariah K. Assessment of depression and anxiety in haematological cancer patients and their relationship with quality of life. East Asian Arch Psychiatry. 2011;21(3):108–14.PubMed Priscilla D, Hamidin A, Azhar MZ, Noorjan KON, Salmiah MS, Bahariah K. Assessment of depression and anxiety in haematological cancer patients and their relationship with quality of life. East Asian Arch Psychiatry. 2011;21(3):108–14.PubMed
13.
Zurück zum Zitat Wittmann M, Vollmer T, Schweiger C, Hiddemann W. The relation between the experience of time and psychological distress in patients with hematological malignancies. Palliat Support Care. 2006;4(04):357–63.CrossRefPubMed Wittmann M, Vollmer T, Schweiger C, Hiddemann W. The relation between the experience of time and psychological distress in patients with hematological malignancies. Palliat Support Care. 2006;4(04):357–63.CrossRefPubMed
14.
Zurück zum Zitat Molassiotis A, Wilson B, Blair S, Howe T, Cavet J. Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psychooncology. 2011;20 doi:10.1002/pon.1710. Molassiotis A, Wilson B, Blair S, Howe T, Cavet J. Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psychooncology. 2011;20 doi:10.​1002/​pon.​1710.
15.
Zurück zum Zitat Hall A, D’Este C, Tzelepis F, Lynagh M, Sanson-Fisher R. Factors associated with haematological cancer survivors experiencing a high level of unmet need across multiple items of supportive care: a cross-sectional survey study. Support Care Cancer. 2014;22(11):2899–909. doi:10.1007/s00520-014-2264-6.CrossRefPubMed Hall A, D’Este C, Tzelepis F, Lynagh M, Sanson-Fisher R. Factors associated with haematological cancer survivors experiencing a high level of unmet need across multiple items of supportive care: a cross-sectional survey study. Support Care Cancer. 2014;22(11):2899–909. doi:10.​1007/​s00520-014-2264-6.CrossRefPubMed
16.
Zurück zum Zitat Hall A, Campbell HS, Sanson-Fisher R, Lynagh M, D’Este C, Burkhalter R, et al. Unmet needs of Australian and Canadian haematological cancer survivors: a cross-sectional international comparative study. Psychooncology. 2013;22(9):2032–8. doi:10.1002/pon.3247.CrossRefPubMed Hall A, Campbell HS, Sanson-Fisher R, Lynagh M, D’Este C, Burkhalter R, et al. Unmet needs of Australian and Canadian haematological cancer survivors: a cross-sectional international comparative study. Psychooncology. 2013;22(9):2032–8. doi:10.​1002/​pon.​3247.CrossRefPubMed
17.
Zurück zum Zitat Rood JA, Zuuren FJ, Stam F, Ploeg T, Eeltink C, Verdonck-de Leeuw IM, et al. Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences. Hemat Oncol. 2015;33(2):85–98. doi:10.1002/hon.2138.CrossRef Rood JA, Zuuren FJ, Stam F, Ploeg T, Eeltink C, Verdonck-de Leeuw IM, et al. Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences. Hemat Oncol. 2015;33(2):85–98. doi:10.​1002/​hon.​2138.CrossRef
18.
Zurück zum Zitat Lobb EA, Joske D, Butow P, Kristjanson LJ, Cannell P, Cull G, et al. When the safety net of treatment has been removed: patients’ unmet needs at the completion of treatment for haematological malignancies. Patient Educ Couns. 2009;77(1):103–8. doi:10.1016/j.pec.2009.02.005.CrossRefPubMed Lobb EA, Joske D, Butow P, Kristjanson LJ, Cannell P, Cull G, et al. When the safety net of treatment has been removed: patients’ unmet needs at the completion of treatment for haematological malignancies. Patient Educ Couns. 2009;77(1):103–8. doi:10.​1016/​j.​pec.​2009.​02.​005.CrossRefPubMed
20.
Zurück zum Zitat Friedman DR, Coan AD, Smith SK, Herndon JE, Abernethy AP. Informational needs assessment of non-Hodgkin lymphoma survivors and their physicians. Am J Hematol. 2010;85(7):528–32.CrossRefPubMedPubMedCentral Friedman DR, Coan AD, Smith SK, Herndon JE, Abernethy AP. Informational needs assessment of non-Hodgkin lymphoma survivors and their physicians. Am J Hematol. 2010;85(7):528–32.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Tariman JD. Treatment decision making in older adults newly diagnosed with myeloma [PhD]: University of Washington; 2011. Tariman JD. Treatment decision making in older adults newly diagnosed with myeloma [PhD]: University of Washington; 2011.
23.
Zurück zum Zitat Australian Bureau of Statistics. 3101.0 Australian Demographic Statistics. Canberra, Australia: Australian Bureau of Statistics 2015 June Quarter. Australian Bureau of Statistics. 3101.0 Australian Demographic Statistics. Canberra, Australia: Australian Bureau of Statistics 2015 June Quarter.
24.
Zurück zum Zitat Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed
26.
Zurück zum Zitat Clinton-McHarg T, Carey M, Sanson-Fisher R, Tzelepis F, Bryant J, Williamson A. Anxiety and depression among haematological cancer patients attending treatment centres: prevalence and predictors. J Affect Disord. 2014;165:176–81.CrossRefPubMed Clinton-McHarg T, Carey M, Sanson-Fisher R, Tzelepis F, Bryant J, Williamson A. Anxiety and depression among haematological cancer patients attending treatment centres: prevalence and predictors. J Affect Disord. 2014;165:176–81.CrossRefPubMed
28.
Zurück zum Zitat Hall AE, Sanson-Fisher RW, Carey ML, Paul C, Williamson A, Bradstock K et al. Prevalence and associates of psychological distress in haematological cancer survivors. Support Care Cancer. 2016:1–10. doi:10.1007/s00520-016-3282-3. Hall AE, Sanson-Fisher RW, Carey ML, Paul C, Williamson A, Bradstock K et al. Prevalence and associates of psychological distress in haematological cancer survivors. Support Care Cancer. 2016:1–10. doi:10.​1007/​s00520-016-3282-3.
29.
Zurück zum Zitat Santos FR, Kozasa EH. Maria de Lourdes L, Colleoni GW, Leite JR. Psychosocial adaptation and quality of life among Brazilian patients with different hematological malignancies. J Psychosom Res. 2006;60(5):505–11.CrossRefPubMed Santos FR, Kozasa EH. Maria de Lourdes L, Colleoni GW, Leite JR. Psychosocial adaptation and quality of life among Brazilian patients with different hematological malignancies. J Psychosom Res. 2006;60(5):505–11.CrossRefPubMed
30.
Zurück zum Zitat Oberoi DV, White V, Jefford M, Giles GG, Bolton D, Davis I et al. Caregivers’ information needs and their ‘experiences of care’ during treatment are associated with elevated anxiety and depression: a cross-sectional study of the caregivers of renal cancer survivors. Support Care Cancer. 2016:1–10. doi:10.1007/s00520-016-3245-8. Oberoi DV, White V, Jefford M, Giles GG, Bolton D, Davis I et al. Caregivers’ information needs and their ‘experiences of care’ during treatment are associated with elevated anxiety and depression: a cross-sectional study of the caregivers of renal cancer survivors. Support Care Cancer. 2016:1–10. doi:10.​1007/​s00520-016-3245-8.
31.
Zurück zum Zitat Maurer MJ HT, Shi Q, Schmitz N, Cunningham D, Pfreundschuh M, Seymour JF, Ulrich Jaeger U et al. Utility of progression-free survival at 24 months (PFS24) to predict subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials: findings from a surrogate endpoint in aggressive lymphoma (SEAL) analysis of individual patient data from 5853 patients. Retrieved from URL https://ash.confex.com/ash/2016/webprogram/Paper90692.html. ASH 58th annual Meeting & Exposition; San Diego, CA: American Society of Haematology; 2016. Maurer MJ HT, Shi Q, Schmitz N, Cunningham D, Pfreundschuh M, Seymour JF, Ulrich Jaeger U et al. Utility of progression-free survival at 24 months (PFS24) to predict subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials: findings from a surrogate endpoint in aggressive lymphoma (SEAL) analysis of individual patient data from 5853 patients. Retrieved from URL https://​ash.​confex.​com/​ash/​2016/​webprogram/​Paper90692.​html. ASH 58th annual Meeting & Exposition; San Diego, CA: American Society of Haematology; 2016.
32.
Zurück zum Zitat Maurer MJ, Ghesquières H, Jais J-P, Witzig TE, Haioun C, Thompson CA, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol. 2014;32(10):1066–73.CrossRefPubMedPubMedCentral Maurer MJ, Ghesquières H, Jais J-P, Witzig TE, Haioun C, Thompson CA, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol. 2014;32(10):1066–73.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Butow PN, Fardell JE, Smith A, editors. Fear of cancer recurrence: an overview and Australian perspective. Cancer Forum; 2015: The Cancer Council Australia. Butow PN, Fardell JE, Smith A, editors. Fear of cancer recurrence: an overview and Australian perspective. Cancer Forum; 2015: The Cancer Council Australia.
34.
Zurück zum Zitat Mutsaers B, Jones G, Rutkowski N, Tomei C, Leclair CS, Petricone-Westwood D, et al. When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence. Support Care Cancer. 2016;1-12 Mutsaers B, Jones G, Rutkowski N, Tomei C, Leclair CS, Petricone-Westwood D, et al. When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence. Support Care Cancer. 2016;1-12
36.
Zurück zum Zitat Korszun A, Sarker SJ, Chowdhury K, Clark C, Greaves P, Johnson R, et al. Psychosocial factors associated with impact of cancer in longterm haematological cancer survivors. Br J Haematol. 2014;164(6):790–803. doi:10.1111/bjh.12698.CrossRefPubMed Korszun A, Sarker SJ, Chowdhury K, Clark C, Greaves P, Johnson R, et al. Psychosocial factors associated with impact of cancer in longterm haematological cancer survivors. Br J Haematol. 2014;164(6):790–803. doi:10.​1111/​bjh.​12698.CrossRefPubMed
38.
Zurück zum Zitat Thompson C, Charlson M, Schenkein E, Wells M, Furman R, Elstrom R, et al. Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann Oncol. 2010;21(11):mdq215. doi:10.1093/annonc/mdq215.CrossRef Thompson C, Charlson M, Schenkein E, Wells M, Furman R, Elstrom R, et al. Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann Oncol. 2010;21(11):mdq215. doi:10.​1093/​annonc/​mdq215.CrossRef
39.
Zurück zum Zitat Munneke N. Relation Between Anxiety and Stress among Cancer Patients and Routine Follow-up: a Review: Tilburg University; 2013. Munneke N. Relation Between Anxiety and Stress among Cancer Patients and Routine Follow-up: a Review: Tilburg University; 2013.
40.
Zurück zum Zitat Azar RM, Nikoogoftar M, Salehi S, Zohoor AR. Anxiety and depression in pre-and-post-hematopoietic stem cell transplants in SCT center, Shariati Hospital, Tehran, Iran. Int J Hematol Oncol Stem Cell Res. 2010;4(4):17–21. Azar RM, Nikoogoftar M, Salehi S, Zohoor AR. Anxiety and depression in pre-and-post-hematopoietic stem cell transplants in SCT center, Shariati Hospital, Tehran, Iran. Int J Hematol Oncol Stem Cell Res. 2010;4(4):17–21.
41.
Zurück zum Zitat Boyes A, Newell S, Girgis A, McElduff P, Sanson-Fisher R. Does routine assessment and real time feedback improve cancer patients’ psychosocial well-being? Eur J Cancer Care (Engl). 2006;15:163.CrossRef Boyes A, Newell S, Girgis A, McElduff P, Sanson-Fisher R. Does routine assessment and real time feedback improve cancer patients’ psychosocial well-being? Eur J Cancer Care (Engl). 2006;15:163.CrossRef
42.
Zurück zum Zitat Clavarino AM, Lowe JB, Carmont S, Balanda K. The needs of cancer patients and their families from rural and remote areas of Queensland. Aust J Rural Health. 2002;10:188–95.CrossRefPubMed Clavarino AM, Lowe JB, Carmont S, Balanda K. The needs of cancer patients and their families from rural and remote areas of Queensland. Aust J Rural Health. 2002;10:188–95.CrossRefPubMed
43.
44.
Zurück zum Zitat Gansler T, Kepner J, Willacy E, Soloe C, Rupert D, Jarblum M, et al. Evolving information priorities of hematologic cancer survivors, caregivers, and other relatives. J Cancer Educ. 2010;25(3):302–11. doi:10.1007/s13187-009-0034-9.CrossRefPubMed Gansler T, Kepner J, Willacy E, Soloe C, Rupert D, Jarblum M, et al. Evolving information priorities of hematologic cancer survivors, caregivers, and other relatives. J Cancer Educ. 2010;25(3):302–11. doi:10.​1007/​s13187-009-0034-9.CrossRefPubMed
45.
Zurück zum Zitat Hjermstad MJ, Evensen SA, Kvaløy SO, Loge JH, Fayers PM, Kaasa S. The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation. Psychooncology. 2003;12(8):803–13.CrossRefPubMed Hjermstad MJ, Evensen SA, Kvaløy SO, Loge JH, Fayers PM, Kaasa S. The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation. Psychooncology. 2003;12(8):803–13.CrossRefPubMed
Metadaten
Titel
The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period
verfasst von
Devesh Oberoi
Victoria White
John Seymour
H. Miles Prince
Simon Harrison
Michael Jefford
Ingrid Winship
David Hill
Damien Bolton
Anne Kay
Jeremy Millar
Nicole Wong Doo
Graham Giles
Publikationsdatum
31.01.2017
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2017
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-016-0591-y

Weitere Artikel der Ausgabe 3/2017

Journal of Cancer Survivorship 3/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.